Hims & Hers Health Inc’s recent filing unveils that its Director Pendarvis Christiane unloaded Company’s shares for reported $0.11 million on Aug 27 ’24. In the deal valued at $15.15 per share,7,000 shares were sold. As a result of this transaction, Pendarvis Christiane now holds 23,917 shares worth roughly $0.35 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Pendarvis Christiane bought 7,000 shares, generating $106,067 in total proceeds.
Before that, Boughton Soleil sold 2,334 shares. Hims & Hers Health Inc shares valued at $39,001 were divested by the Chief Legal Officer at a price of $16.71 per share. As a result of the transaction, Boughton Soleil now holds 162,141 shares, worth roughly $2.39 million.
Needham initiated its Hims & Hers Health Inc [HIMS] rating to a Buy in a research note published on August 22, 2024; the price target was $24. A number of analysts have revised their coverage, including Imperial Capital’s analysts, who decreased its forecast for the stock in early August from “an Outperform” to “an In-line”. Citigroup also remained covering HIMS and has decreased its forecast on May 22, 2024 with a “Neutral” recommendation from previously “Buy” rating. Jefferies revised its rating on April 16, 2024. It rated HIMS as “a Hold” which previously was an “a Buy”.
Price Performance Review of HIMS
On Friday, Hims & Hers Health Inc [NYSE:HIMS] saw its stock unchanged to $14.73. Over the last five days, the stock has lost -11.95%. Hims & Hers Health Inc shares have risen nearly 65.51% since the year began. Nevertheless, the stocks have risen 112.25% over the past one year. While a 52-week high of $25.74 was reached on 06/18/24, a 52-week low of $5.65 was recorded on 01/05/24. SMA at 50 days reached $19.10, while 200 days put it at $14.16.
Levels Of Support And Resistance For HIMS Stock
The 24-hour chart illustrates a support level at 14.42, which if violated will result in even more drops to 14.11. On the upside, there is a resistance level at 14.99. A further resistance level may holdings at 15.25. The Relative Strength Index (RSI) on the 14-day chart is 31.91, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.05, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 88.89%. Stochastics %K at 9.62% indicates the stock is a buying.
How much short interest is there in Hims & Hers Health Inc?
A steep rise in short interest was recorded in Hims & Hers Health Inc stocks on 2024-08-15, growing by 3.23 million shares to a total of 23.04 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-15 was 19.81 million shares. There was a rise of 14.02%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on April 10, 2024 when Canaccord Genuity began covering the stock and recommended ‘”a Buy”‘ rating along with a $20 price target.
